Back to search
Advanced ALK/ROS1-positive NSCLC
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced ALK/ROS1-positive NSCLC trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced ALK/ROS1-positive NSCLC trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this first-in-patient, open label study is to determine the maximum tolerated dose and/or recommended dose for further study of PF-07284892 as a…
This phase I trial studies the side effects and best dose of ceritinib and everolimus in treating patients with solid tumors that have spread from where they st…